Strategy (MSTR) CEO Says Bitcoin Still Leads As Institutions And Stablecoins Buy In

  • CEO Phong Le reaffirmed Bitcoin's market leadership, citing institutional and stablecoin adoption.
  • He highlighted Strategy Inc. (NasdaqGS:MSTR) as the largest corporate buyer of Bitcoin.
  • The comments come as crypto regulation shows signs of a more accommodative tone and big banks increase involvement.

Strategy, trading under NasdaqGS:MSTR, is putting its Bitcoin thesis front and center, with CEO Phong Le underscoring the company’s commitment to the asset. The stock closed at $100.01, with a value score of 4 and a mixed return profile, including a gain of 125.5% over 3 years and 54.7% over 5 years, but a decline of 36.4% year to date and 75.8% over the past year. In the short term, the shares are up 2.6% over the past week and down 8.6% over the past month.

For investors watching Strategy, Le’s comments link the company’s Bitcoin holdings directly to recent macro shifts, such as institutional buying momentum and a clearer regulatory stance. The emphasis on Bitcoin as a core corporate asset, alongside growing big bank involvement in crypto, indicates that management is closely aligning corporate decisions with developments in the wider digital asset market.

Stay updated on the most important news stories for Strategy by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Strategy.

NasdaqGS:MSTR 1-Year Stock Price Chart
NasdaqGS:MSTR 1-Year Stock Price Chart

Does the team leading Strategy have what it takes? See our full breakdown of the management team's track record and compensation.

Advertisement

Quick Assessment

  • ✅ Price vs Analyst Target: Strategy trades at US$100.01 versus a consensus target of US$303.64, around 67% below analyst expectations.
  • ✅ Simply Wall St Valuation: Shares are assessed as trading 39.8% below estimated fair value, suggesting a valuation gap.
  • ❌ Recent Momentum: The stock is down 8.6% over the past 30 days, showing weak short term price momentum.

There's only one way to know the right time to buy, sell or hold Strategy. Head to Simply Wall St's company report for the latest analysis of Strategy's Fair Value.

Key Considerations

  • 📊 Phong Le’s focus on Bitcoin dominance ties Strategy’s equity story even more tightly to institutional and stablecoin driven demand for the asset.
  • 📊 Watch the Bitcoin price, changes in crypto regulation tone, and any updates to Strategy’s Bitcoin holdings versus its software operations.
  • ⚠️ The flagged risk of shareholder dilution over the past year, combined with heavy Bitcoin exposure, means investors need to track capital raises and balance sheet moves closely.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Strategy analysis. Alternatively, you can check out the community page for Strategy to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:MSTR

Strategy

Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.

Excellent balance sheet with moderate growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
48 users have followed this narrative
2 users have commented on this narrative
8 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7720.1% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
83 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
190 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0